In this video, Laura T. Safar, MD, discusses psychotropic treatment as one of several potential tools for the management of neuropsychiatric disorders among patients with multiple sclerosis. She recently...
Charles Brenner, PhD, director of the Obesity Initiative at the University of Iowa, discusses properties of nicotinamide riboside that have been uncovered since its initial discovery in 2004.
